BVF INC/IL

SAN FRANCISCO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$3.04B2026 Q3
Positions47
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.66.0%

BVF INC/IL reported 47 positions worth $3.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RVMD (16.6%). Biggest move: exit XOMAGBP ($322.7M).

10 / 47 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RVMDRevolution Medicines$505.1M16.61%2,460,560——-18.7%
▸ 2 KYMRKymera Therapeutics$432.9M14.24%3,872,052——+14.1%
▸ 3 GHRSGH Research$203.1M6.68%8,650,158———
▸ 4 MLTXMoonLake Immunotherapeutics$187.2M6.16%16,001,284——+2.0%
▸ 5 XNCRXencor$155.4M5.11%6,227,034——+41.9%
▸ 6 NKTRNektar Therapeutics$129.2M4.25%2,134,007——-38.4%
▸ 7 ALKSAlkermes$115.4M3.79%2,847,100——+14.8%
▸ 8 STOKStoke Therapeutics$93.8M3.09%3,608,968——+2.4%
▸ 9 TYRATyra Biosciences$92.2M3.03%4,215,886——-8.5%
▸ 10 ZYMEZymeworks$91.8M3.02%3,464,142——-0.9%

Pro Feature

The remaining 37 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does BVF INC/IL hold as of Q3 2026?

BVF INC/IL reported 47 positions worth $3.04B in its Q3 2026 13F filing. Largest positions: RVMD (16.6%), KYMR (14.2%), GHRS (6.7%), MLTX (6.2%) and XNCR (5.1%).

What did BVF INC/IL buy in Q3 2026?

New positions: PYXS, ALEC, TCGX ACQUISITION CORP and RESEARCH ALLIANCE CORP IV. Added to: TYRA, ENTERA BIO LTD, ALKS, STOK and SGMT (7 in all).

What did BVF INC/IL sell in Q3 2026?

Reduced: RVMD, IRON, MIRM, XNCR and GPCR (15 in all). Sold out entirely: XOMAGBP.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.